Flinton Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Flinton Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$102K	Buy	12,304 +336	+3%	+$2.72K	﹤0.01%	767
2019 Q2	$103K	Buy	11,968 +1,584	+15%	+$14.2K	﹤0.01%	776
2019 Q1	$111K	Hold	10,384	–	–	﹤0.01%	761
2018 Q4	$91K	Buy	10,384 +1,744	+20%	+$22.2K	﹤0.01%	758
2018 Q3	$145K	Buy	8,640 +752	+10%	+$16.3K	﹤0.01%	750
2018 Q2	$165K	Hold	7,888	–	–	0.01%	691
2018 Q1	$127K	Buy	7,888 +800	+11%	+$15.8K	﹤0.01%	724
2017 Q4	$134K	Buy	7,088 +3,728	+111%	+$67.5K	﹤0.01%	726
2017 Q3	$47K	Buy	+3,360	New	+$30.4K	﹤0.01%	807

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Flinton Capital Management's SPPI Position: Q3 2019 in Review

Flinton Capital Management increased its Spectrum Pharmaceuticals Inc (SPPI) stake by 2.8% in Q3 2019, buying an estimated $2.72K and bringing the position to 12,304 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #767.

Flinton Capital Management first reported a position in SPPI in Q3 2017 and has held it in 9 quarters since. The position peaked at $165K in Q2 2018. 167 funds tracked by Wall St. Rank hold SPPI as of Q3 2019.

Flinton Capital Management held 12,304 shares of Spectrum Pharmaceuticals Inc worth $102K as of Q3 2019.
Flinton Capital Management bought 336 Spectrum Pharmaceuticals Inc shares in Q3 2019, an estimated $2.72K.
Spectrum Pharmaceuticals Inc made up ﹤0.01% of Flinton Capital Management's portfolio in Q3 2019, its #767 holding.
Flinton Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2017 and has held it in 9 quarters since.
Flinton Capital Management's Spectrum Pharmaceuticals Inc position peaked at $165K in Q2 2018.
167 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.